BRPI0807318B8 - "microrna associado a exossomos como marcador diagnóstico" - Google Patents
"microrna associado a exossomos como marcador diagnóstico"Info
- Publication number
- BRPI0807318B8 BRPI0807318B8 BRPI0807318A BRPI0807318A BRPI0807318B8 BR PI0807318 B8 BRPI0807318 B8 BR PI0807318B8 BR PI0807318 A BRPI0807318 A BR PI0807318A BR PI0807318 A BRPI0807318 A BR PI0807318A BR PI0807318 B8 BRPI0807318 B8 BR PI0807318B8
- Authority
- BR
- Brazil
- Prior art keywords
- exosomes
- micron
- diagnostic marker
- individual
- present
- Prior art date
Links
- 210000001808 exosome Anatomy 0.000 title abstract 3
- 239000003550 marker Substances 0.000 title abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 201000011510 cancer Diseases 0.000 abstract 2
- 230000002411 adverse Effects 0.000 abstract 1
- 239000012472 biological sample Substances 0.000 abstract 1
- 230000035935 pregnancy Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57423—Specifically defined cancers of lung
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57449—Specifically defined cancers of ovaries
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57492—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
-
- G—PHYSICS
- G07—CHECKING-DEVICES
- G07F—COIN-FREED OR LIKE APPARATUS
- G07F17/00—Coin-freed apparatus for hiring articles; Coin-freed facilities or services
- G07F17/32—Coin-freed apparatus for hiring articles; Coin-freed facilities or services for games, toys, sports, or amusements
- G07F17/3202—Hardware aspects of a gaming system, e.g. components, construction, architecture thereof
- G07F17/3204—Player-machine interfaces
- G07F17/3211—Display means
-
- G—PHYSICS
- G07—CHECKING-DEVICES
- G07F—COIN-FREED OR LIKE APPARATUS
- G07F17/00—Coin-freed apparatus for hiring articles; Coin-freed facilities or services
- G07F17/32—Coin-freed apparatus for hiring articles; Coin-freed facilities or services for games, toys, sports, or amusements
- G07F17/3244—Payment aspects of a gaming system, e.g. payment schemes, setting payout ratio, bonus or consolation prizes
- G07F17/3258—Cumulative reward schemes, e.g. jackpots
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
- Y10T436/143333—Saccharide [e.g., DNA, etc.]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- General Physics & Mathematics (AREA)
- Hospice & Palliative Care (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Steroid Compounds (AREA)
Abstract
microrna associado a exossomos como marcador diagnóstico a matéria revelada na presente invenção provê métodos para o diagnóstico de câncer ou de resultados adversos de gestações em um indivíduo por meio da medição das quantidades de um ou mais micrornas presentes em exossomos derivados de câncer de uma amostra biológica de um indivíduo.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US95181207P | 2007-07-25 | 2007-07-25 | |
US5043808P | 2008-05-05 | 2008-05-05 | |
PCT/US2008/071235 WO2009015357A1 (en) | 2007-07-25 | 2008-07-25 | Exosome-associated microrna as a diagnostic marker |
Publications (3)
Publication Number | Publication Date |
---|---|
BRPI0807318A2 BRPI0807318A2 (pt) | 2015-03-24 |
BRPI0807318B1 BRPI0807318B1 (pt) | 2018-11-13 |
BRPI0807318B8 true BRPI0807318B8 (pt) | 2021-07-27 |
Family
ID=40281854
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0807318A BRPI0807318B8 (pt) | 2007-07-25 | 2008-07-25 | "microrna associado a exossomos como marcador diagnóstico" |
Country Status (11)
Country | Link |
---|---|
US (5) | US8216784B2 (pt) |
EP (3) | EP2613149B1 (pt) |
JP (3) | JP5156829B2 (pt) |
CN (2) | CN103276062A (pt) |
AU (1) | AU2008279016B2 (pt) |
BR (1) | BRPI0807318B8 (pt) |
CA (1) | CA2676113C (pt) |
ES (1) | ES2420973T3 (pt) |
GB (1) | GB2459228B (pt) |
IL (3) | IL200028A (pt) |
WO (1) | WO2009015357A1 (pt) |
Families Citing this family (176)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8021847B2 (en) | 2004-06-02 | 2011-09-20 | Proxy Life Science Holdings, Inc. | Microvesicle-based compositions and methods |
EP1766053A4 (en) * | 2004-06-02 | 2007-12-12 | Sourcepharm Inc | MICROVESICLES CONTAINING RNA AND METHODS |
EP2468899B1 (en) | 2006-01-05 | 2015-03-11 | The Ohio State University Research Foundation | MicroRNA-based methods for the diagnosis of stomach cancers |
ES2880460T3 (es) * | 2006-03-09 | 2021-11-24 | Aethlon Medical Inc | Eliminación extracorpórea de partículas microvesiculares |
AU2007227423B2 (en) | 2006-03-20 | 2013-11-07 | The Ohio State University Research Foundation | MicroRNA fingerprints during human megakaryocytopoiesis |
EP2610347B1 (en) * | 2007-04-30 | 2015-04-15 | The Ohio State University Research Foundation | Methods of determining the prognosis of a subject with pancreatic cancer |
EP2613149B1 (en) * | 2007-07-25 | 2014-09-17 | University Of Louisville Research Foundation, Inc. | Exosome-associated microRNA as a diagnostic marker |
CN103866008B (zh) | 2007-08-03 | 2016-06-29 | 俄亥俄州立大学研究基金会 | 编码ncrna的超保守区域 |
US20100255514A1 (en) * | 2007-08-16 | 2010-10-07 | The Royal Institution For The Advancement Of Learning/Mcgill University | Tumor cell-derived microvesicles |
JP5769417B2 (ja) | 2007-08-16 | 2015-08-26 | ザ ロイヤル インスティチューション フォー ザ アドバンスメント オブ ラーニング/マギル ユニバーシティ | 腫瘍細胞由来微小胞 |
EP2775001B1 (en) * | 2007-09-06 | 2016-03-09 | The Ohio State University Research Foundation | MicroRNA signatures in human ovarian cancer |
CA2699646A1 (en) * | 2007-09-14 | 2009-03-19 | The Ohio State University Research Foundation | Mirna expression in human peripheral blood microvesicles and uses thereof |
US20100285471A1 (en) * | 2007-10-11 | 2010-11-11 | The Ohio State University Research Foundation | Methods and Compositions for the Diagnosis and Treatment of Esphageal Adenocarcinomas |
CN101424640B (zh) * | 2007-11-02 | 2012-07-25 | 江苏命码生物科技有限公司 | 血清中微小核糖核酸的检测方法和用于检测的试剂盒、生物芯片及其制作和应用方法 |
CA2708661A1 (en) * | 2008-01-27 | 2009-07-30 | Rosetta Genomics Ltd. | Methods and compositions for diagnosing complications of pregnancy |
CN102084000B (zh) * | 2008-02-01 | 2016-03-16 | 总医院有限公司 | 微泡在医学疾病和病况的诊断、预后以及治疗中的用途 |
US20110034538A1 (en) * | 2008-02-28 | 2011-02-10 | The Ohio State University Research Foundation | MicroRNA-Based Methods and Compositions for the Diagnosis, Prognosis and Treatment of Gastric Cancer |
US20110177054A1 (en) * | 2008-06-06 | 2011-07-21 | Derrick Gibbings | Use of endo-lysosomal system and secreted vesicles (exosome-like) in treatments and diagnostics based on small rna and experimental study of small rna |
US9410956B1 (en) * | 2008-08-01 | 2016-08-09 | University Of South Florida | Micro-RNA profiling in ovarian cancer |
US9487837B2 (en) | 2008-10-06 | 2016-11-08 | Morehouse School Of Medicine | Exosome-mediated diagnosis of hepatitis virus infections and diseases |
CA2742324A1 (en) | 2008-10-30 | 2010-06-03 | Caris Life Sciences Luxembourg Holdings, S.A.R.L. | Methods for assessing rna patterns |
CN102301002A (zh) * | 2008-11-12 | 2011-12-28 | 卡里斯生命科学卢森堡控股有限责任公司 | 使用外来体来确定表现型的方法和系统 |
CN101475984A (zh) * | 2008-12-15 | 2009-07-08 | 江苏命码生物科技有限公司 | 一种非小细胞肺癌检测标记物及其检测方法、相关生物芯片和试剂盒 |
AU2010205493A1 (en) * | 2009-01-19 | 2011-09-08 | Sistemic Scotland Limited | Methods employing non-coding RNA expression assays |
US20120115139A1 (en) * | 2009-04-21 | 2012-05-10 | Tokyo Medical University | Method for evaluating cancer |
US20120077263A1 (en) * | 2009-06-05 | 2012-03-29 | Mayo Foundation For Medical Education And Research | Methods and materials for isolating exosomes |
JP5909444B2 (ja) * | 2009-07-16 | 2016-04-26 | ザ ジェネラル ホスピタル コーポレイション | 核酸分析 |
CN101988062A (zh) * | 2009-07-30 | 2011-03-23 | 江苏命码生物科技有限公司 | 宫颈癌检测标记物及其检测方法、试剂盒和生物芯片 |
US8735074B2 (en) * | 2009-08-28 | 2014-05-27 | Asuragen, Inc. | MiRNA biomarkers of lung disease |
WO2011031892A1 (en) | 2009-09-09 | 2011-03-17 | The General Hospital Corporation | Use of microvesicles in analyzing kras mutations |
WO2011031877A1 (en) | 2009-09-09 | 2011-03-17 | The General Hospital Corporation | Use of microvesicles in analyzing nucleic acid profiles |
WO2011044541A2 (en) * | 2009-10-09 | 2011-04-14 | Baylor Research Institute | Identification of micrornas (mirnas) in fecal samples as biomarkers for gastroenterological cancers |
EP2316972A1 (en) * | 2009-10-29 | 2011-05-04 | Deutsches Krebsforschungszentrum | Circulating miRNAs as non-invasive markers for diagnosis and staging in prostate cancer |
WO2011057003A2 (en) | 2009-11-04 | 2011-05-12 | Samuil Umansky | Methods of using small rna from bodily fluids for diagnosis and monitoring of neurodegenerative diseases |
CN101798594A (zh) * | 2009-11-13 | 2010-08-11 | 北京命码生科科技有限公司 | 检测牛乳质量的标志物、检测方法、生物芯片和试验盒 |
WO2011063324A2 (en) * | 2009-11-20 | 2011-05-26 | The General Hospital Corporation | Microfluidic systems for isolating microvesicles |
CN102803511A (zh) | 2009-11-23 | 2012-11-28 | 俄亥俄州立大学 | 用于影响肿瘤细胞生长、迁移和侵袭的材料和方法 |
EP2341145A1 (en) | 2009-12-30 | 2011-07-06 | febit holding GmbH | miRNA fingerprint in the diagnosis of diseases |
JP5808349B2 (ja) * | 2010-03-01 | 2015-11-10 | カリス ライフ サイエンシズ スウィッツァーランド ホールディングスゲーエムベーハー | セラノーシスのためのバイオマーカー |
JP2013526852A (ja) * | 2010-04-06 | 2013-06-27 | カリス ライフ サイエンシズ ルクセンブルク ホールディングス | 疾患に対する循環バイオマーカー |
EP2559442B1 (en) * | 2010-04-13 | 2017-12-06 | Jiangsu Mingma Biotech Co., Ltd | Method for regulating microrna content in organisms and uses thereof |
US20130203081A1 (en) * | 2010-04-13 | 2013-08-08 | Janusz Rak | Tumor cell-derived microvesicles |
WO2011156763A1 (en) | 2010-06-11 | 2011-12-15 | Hitachi Chemical Co., Ltd. | Methods for characterizing kidney function |
WO2011156734A2 (en) * | 2010-06-11 | 2011-12-15 | Hitachi Chemical Co., Ltd. | Method of characterizing vascular diseases |
ES2624284T3 (es) * | 2010-07-07 | 2017-07-13 | Aethlon Medical Inc | Métodos para cuantificar exosomas |
US20140045915A1 (en) | 2010-08-31 | 2014-02-13 | The General Hospital Corporation | Cancer-related biological materials in microvesicles |
CN101921759B (zh) * | 2010-09-08 | 2013-05-29 | 南京医科大学 | 一种与宫颈癌及其癌前病变相关的血清/血浆miRNA标志物及其应用 |
EP2446929A1 (en) * | 2010-10-27 | 2012-05-02 | Johann Wolfgang Goethe-Universität Frankfurt am Main | Microvesicles derived from atheroprotective endothelial cells for the treatment and prevention of atherosclerotic diseases |
US20120107825A1 (en) | 2010-11-01 | 2012-05-03 | Winger Edward E | Methods and compositions for assessing patients with reproductive failure using immune cell-derived microrna |
WO2012064993A1 (en) | 2010-11-10 | 2012-05-18 | Exosome Diagnosties, Inc. | Method for isolation of nucleic acid containing particles and extraction of nucleic acids therefrom |
AU2011326032B2 (en) | 2010-11-12 | 2016-10-06 | The Ohio State University Research Foundation | Materials and methods related to microRNA-21, mismatch repair, and colorectal cancer |
BR112013011942A2 (pt) | 2010-11-15 | 2016-11-01 | Univ Michigan | formulação, forma de dosagem de droga para administração transmucosa oral, sistema transmucoso de fornecimento de droga, método de tratamento e profilaxia de uma doença ou distúrbio, método de tratamento, formulação, método para tratamento ou prevenção de carcinoma de célula escamosa de cabeça e pescoço (hnscc), método para quimioprevenção de um câncer oral ou condição pré-cancerosa, método para aumentar a concentração de uma composição de retinida, método de tratamento e profilaxia de uma doença ou condição, método de ratamento de um sujeito apresentando uma condição médica sintomática, método de tratamento de um câncer oral ou condição pré-cancerosa num paciente, método para fazer um sistema de fornecimento de droga bucal, método para aumentar a liberação e permeação de uma composição de retinida. |
JP2012125215A (ja) * | 2010-12-17 | 2012-07-05 | Osaka City Univ | 肝線維症の存在及び/又は肝線維症の重症度の判定方法、判定マーカー、判定用キット、肝線維症の治療の効果予測方法、効果予測マーカー、並びに効果予測用キット |
EP2505663A1 (en) * | 2011-03-30 | 2012-10-03 | IFOM Fondazione Istituto Firc di Oncologia Molecolare | A method to identify asymptomatic high-risk individuals with early stage lung cancer by means of detecting miRNAs in biologic fluids |
CN105861712B (zh) | 2011-04-18 | 2021-05-14 | 迪阿米尔有限责任公司 | 使用来自体液的miRNA来早期检测和监控轻度认知障碍(MCI)和阿尔茨海默病(AD)的方法 |
EP2707381B1 (en) * | 2011-05-11 | 2019-08-14 | Exosome Diagnostics, Inc. | Nucleic acid extraction from heterogeneous biological materials |
EP2717989B1 (en) | 2011-06-10 | 2018-05-30 | Hitachi Chemical Co., Ltd. | Vesicle capturing devices and methods for using same |
US20140275211A1 (en) * | 2011-06-21 | 2014-09-18 | Alnylam Pharmaceuticals, Inc. | Assays and methods for determining activity of a therapeutic agent in a subject |
BR112013033488B8 (pt) * | 2011-06-27 | 2022-11-22 | Eisai R&D Man Co Ltd | Métodos para facilitar o diagnóstico do comprometimento cognitivo devido a doença de alzheimer ou comprometimento cognitivo leve (mci)e kit |
CA2846211A1 (en) * | 2011-08-05 | 2013-02-14 | University Of Louisville Research Foundation, Inc. | Microrna biomarkers |
EP2742154A4 (en) * | 2011-08-08 | 2015-08-12 | Caris Life Sciences Switzerland Holdings Gmbh | BIOMARKER COMPOSITIONS AND METHODS |
AU2012323924A1 (en) * | 2011-10-14 | 2014-05-29 | The Ohio State University | Methods and materials related to ovarian cancer |
EP2584040A1 (en) * | 2011-10-17 | 2013-04-24 | Pharmahungary 2000 Kft. | Compounds for treatment of ischemic injury |
WO2013066678A1 (en) * | 2011-10-26 | 2013-05-10 | Georgetown University | Microrna expression profiling of thyroid cancer |
WO2013063439A1 (en) * | 2011-10-27 | 2013-05-02 | University Of Louisville Research Foundation, Inc. | Characterizing melanoma |
WO2013070324A1 (en) | 2011-11-07 | 2013-05-16 | University Of Louisville Research Foundation, Inc. | Edible plant-derived microvesicle compositions for diagnosis and treatment of disease |
WO2013079701A2 (en) * | 2011-11-30 | 2013-06-06 | University Of Bremen | Expression of mirnas in placental tissue |
CN104619353A (zh) * | 2011-12-13 | 2015-05-13 | 俄亥俄州国家创新基金会 | 与miR-21和miR-29a相关的方法和组合物、外切体抑制和癌症转移 |
US9447471B2 (en) | 2011-12-29 | 2016-09-20 | Quest Diagnostics Investments Incorporated | Microrna profiling for diagnosis of dysplastic nevi and melanoma |
AU2013209477B2 (en) | 2012-01-20 | 2016-12-08 | The Ohio State University | Breast cancer biomarker signatures for invasiveness and prognosis |
EP2818549A4 (en) | 2012-02-23 | 2015-09-02 | Sumitomo Bakelite Co | METHOD FOR CLASSIFYING BODY FLUID SAMPLE OF TEST |
US20130273549A1 (en) * | 2012-04-16 | 2013-10-17 | Board Of Regents, The University Of Texas System | Detection of extracellular jcv micrornas |
WO2013155633A1 (en) * | 2012-04-19 | 2013-10-24 | Leong Hon Sing | Method for detecting or monitoring prostate cancer |
CA2882248A1 (en) | 2012-08-15 | 2014-02-20 | The University Of Chicago | Exosome-based therapeutics against neurodegenerative disorders |
EP2886122B1 (en) * | 2012-08-20 | 2019-02-27 | National Cancer Center | Agent for treating cancer |
CN102864224A (zh) * | 2012-09-11 | 2013-01-09 | 南京大学 | 一种血清microRNAs试剂盒及其应用 |
WO2014041087A1 (en) | 2012-09-12 | 2014-03-20 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Muscle secretome and uses thereof |
US9255924B2 (en) | 2012-10-12 | 2016-02-09 | University Of Notre Dame Du Lac | Exosomes and diagnostic biomarkers |
US10942184B2 (en) | 2012-10-23 | 2021-03-09 | Caris Science, Inc. | Aptamers and uses thereof |
EP4170031A1 (en) * | 2012-10-23 | 2023-04-26 | Caris Science, Inc. | Aptamers and uses thereof |
EP2746406B1 (en) * | 2012-12-18 | 2017-08-23 | Samsung Electronics Co., Ltd. | Composition and kit for diagnosing breast cancer including miRNAs within vesicle, and method of diagnosing breast cancer using the same |
WO2014100434A1 (en) | 2012-12-19 | 2014-06-26 | Caris Science, Inc. | Compositions and methods for aptamer screening |
US9086412B2 (en) * | 2012-12-31 | 2015-07-21 | University Of Louisville Research Foundation, Inc. | Extracellular vesicle-associated protein markers of cancer |
WO2014160032A1 (en) * | 2013-03-13 | 2014-10-02 | University Of Louisville Research Foundation, Inc. | Exosome-associated rna as a diagnostic marker |
JP6562897B2 (ja) | 2013-03-13 | 2019-08-21 | ユニバーシティー オブ マイアミUniversity Of Miami | 細胞培養上清および生体液からの微小胞の単離および精製のための方法 |
MX2015013141A (es) * | 2013-03-15 | 2016-06-21 | Univ Texas | Biogénesis de miarn en exosomas para diagnóstico y terapia. |
CA2907377A1 (en) * | 2013-03-15 | 2014-09-18 | Baylor Research Institute | Tissue and blood-based mirna biomarkers for the diagnosis, prognosis and metastasis-predictive potential in colorectal cancer |
DE102013103447A1 (de) * | 2013-04-05 | 2014-10-09 | Bodo C. Melnik | Verfahren und Vorrichtung zur Herstellung kommerzieller Milch und Milch mit reduzierter biologischer Wirkung exosomaler Ribonukleinsäuren |
JP6297676B2 (ja) | 2013-05-06 | 2018-03-20 | 日立化成株式会社 | 標的分子を捕捉するためのデバイス及び方法 |
US9213029B2 (en) | 2013-06-25 | 2015-12-15 | Samsung Electronics Co., Ltd. | Method for diagnosing breast cancer by detection of polymeric immunoglobulin receptor in vesicles isolated from patients |
EP3030675B1 (en) * | 2013-08-06 | 2018-10-03 | Exosome Diagnostics Inc. | Urine biomarker cohorts, gene expression signatures, and methods of use thereof |
WO2015045666A1 (ja) | 2013-09-25 | 2015-04-02 | 国立大学法人東京大学 | 流体デバイス、エキソソームの分析方法、生体分子分析方法及び生体分子検出方法 |
PL405648A1 (pl) | 2013-10-15 | 2015-04-27 | Warszawski Uniwersytet Medyczny | Sposób diagnozowania raka watrobowokomórkowego, zastosowanie markera mikroRNA do diagnozowania zmiany chorobowej w obrębie wątroby, oceny stopnia zaawansowania choroby oraz oceny podatności pacjenta i/lub choroby na zaproponowane leczenie oraz zawierający takie markery zestaw diagnostyczny |
KR20150043937A (ko) | 2013-10-15 | 2015-04-23 | 삼성전자주식회사 | 개체의 간암 진단용 조성물, 개체의 간암 진단하는 방법 및 개체의 간암 진단에 필요한 정보를 얻는 방법 |
EP3058101A4 (en) * | 2013-10-15 | 2017-05-17 | The Board of Trustees of the University of Illionis | Serum mirnas for the prognosis of prostate cancer |
JP6547625B2 (ja) | 2013-10-25 | 2019-07-24 | 凸版印刷株式会社 | 膜小胞回収デバイス、膜小胞回収方法、及び膜小胞分析方法 |
PL406033A1 (pl) | 2013-11-14 | 2015-05-25 | Warszawski Uniwersytet Medyczny | Sposób diagnozowania raka brodawkowatego tarczycy, zastosowanie markera mikroRNA do diagnozowania nowotworu tarczycy, oceny stopnia zaawansowania choroby oraz oceny podatności pacjenta i/lub choroby na zaproponowane leczenie oraz zawierający takie markery zestaw diagnostyczny |
CA2931082C (en) | 2013-11-18 | 2024-01-23 | Diamir, Llc | Methods of using mirnas from bodily fluids for detection and monitoring of parkinson's disease (pd) |
FR3014198B1 (fr) * | 2013-12-03 | 2017-03-03 | Biomerieux Sa | Procede d'isolement d'exosomes |
KR101535737B1 (ko) * | 2014-01-09 | 2015-07-09 | 충남대학교산학협력단 | miRNA를 포함하는 자간전증 진단 및 치료용 조성물 |
CN106574927A (zh) * | 2014-01-14 | 2017-04-19 | 崔元哲 | 使用luterial的形态学特征筛选癌症预防剂或抗癌剂的方法 |
WO2015126886A1 (en) | 2014-02-18 | 2015-08-27 | Baylor Research Institute | Mir-320e and colorectal cancer |
CA2940823C (en) * | 2014-02-27 | 2017-03-28 | Board Of Regents, The University Of Texas System | Methods and compositions for isolating exosomes |
CN103937888B (zh) * | 2014-04-14 | 2016-08-17 | 上海交通大学 | 鉴别胃癌的血浆microRNA标志物的筛选与应用 |
CN103954770B (zh) * | 2014-04-25 | 2015-09-30 | 江南大学 | EVs-TRPC5在检测乳腺癌耐药程度中的应用 |
CN103993015B (zh) * | 2014-05-23 | 2016-04-27 | 山西医科大学 | 人类子痫前期发生相关的外周血白细胞miRNA标志物及其应用 |
CA2951016A1 (en) * | 2014-06-12 | 2015-12-17 | Toray Industries, Inc. | Prostate cancer detection kit or device, and detection method |
JP6597614B2 (ja) | 2014-07-24 | 2019-10-30 | 凸版印刷株式会社 | 脂質膜構造体、脂質膜構造体固定化担体、及び胞体の融合方法 |
KR101784714B1 (ko) | 2014-08-19 | 2017-10-12 | 주식회사 엠모니터 | 재발 난소암 진단 또는 난소암 재발 예측용 mirna 마커 및 그 용도 |
US20170298352A1 (en) | 2014-09-30 | 2017-10-19 | Research Institute at Nationwide Children's Hospit al | Compositions and methods for treating hepatic fibrosis |
WO2016057474A1 (en) * | 2014-10-06 | 2016-04-14 | Indiana University Research & Technology Corporation | Systems and methods for localized surface plasmon resonance biosensing |
RU2571507C1 (ru) * | 2014-10-09 | 2015-12-20 | Федеральное государственное бюджетное учреждение науки Институт химической биологии и фундаментальной медицины Сибирского отделения Российской академии наук (ИХБФМ СО РАН) | Способ диагностики и мониторинга онкологических заболеваний с использованием экзосом крови |
US10266895B2 (en) | 2014-11-05 | 2019-04-23 | Hitachi Chemical Company Ltd. | Exosomes and microvesicles in intestinal luminal fluids and stool and use of same for the assessment of inflammatory bowel disease |
JP6631852B2 (ja) | 2014-11-12 | 2020-01-15 | 日立化成株式会社 | 臓器障害を診断するための方法および装置 |
WO2016094722A1 (en) | 2014-12-10 | 2016-06-16 | Xpecting Diagnostics, Inc. | Detection of analytes in bodily fluid to determine the initiation of parturition |
EP3250706A4 (en) * | 2015-01-30 | 2018-09-05 | The Johns Hopkins University | Extracellular vesicles for agent delivery |
WO2016140388A1 (ko) * | 2015-03-05 | 2016-09-09 | 경북대학교 산학협력단 | 엑소좀 또는 이의 단백질을 포함하는 장기 독성 진단용 바이오마커 조성물 및 이를 이용한 진단 방법 |
US10071133B2 (en) * | 2015-03-12 | 2018-09-11 | Mitsui Chemicals, Inc. | Method for destroying exosomes, kit for destroying exosomes, and method for isolating exosomes derived from normal cells |
GB201504772D0 (en) * | 2015-03-20 | 2015-05-06 | Univ Aston | Preeclampsia |
US20160320390A1 (en) * | 2015-05-01 | 2016-11-03 | Morehouse School Of Medicine | Compositions and methods for capturing exosomes |
JP6777629B2 (ja) * | 2015-05-20 | 2020-10-28 | Jsr株式会社 | 分離方法、検出方法、シグナル測定方法、疾患の判定方法、薬効評価方法、キット、液状組成物及び検体希釈液 |
US10345310B2 (en) | 2015-06-09 | 2019-07-09 | The Board Of Regents Of The University Of Texas System | Diagnostic test for early stage cancer |
AU2016276942B2 (en) | 2015-06-10 | 2022-08-25 | Children's National Medical Center | Adipocyte-derived exosomes, and compositions, kits, and methods of using the same for detection and screening |
EP3307890A1 (en) | 2015-06-10 | 2018-04-18 | Board of Regents, The University of Texas System | Use of exosomes for the treatment of disease |
CN106319031A (zh) * | 2015-06-23 | 2017-01-11 | 上海市计划生育科学研究所 | 反复自然流产相关微小rna及其应用 |
AU2016287499B2 (en) | 2015-06-29 | 2022-08-04 | Caris Science, Inc. | Therapeutic oligonucleotides |
CA2993652A1 (en) | 2015-07-28 | 2017-02-02 | Caris Science, Inc. | Targeted oligonucleotides |
DE112016003948T5 (de) | 2015-08-31 | 2018-05-09 | City Of Sapporo | Molekulare verfahren zum beurteilen einer urothelialen erkrankung |
CN109477144B (zh) | 2015-09-29 | 2022-12-09 | 国家儿童医院研究所 | 用于检测肝脏纤维化和对疗法的响应性的方法 |
KR101695347B1 (ko) * | 2015-10-12 | 2017-01-11 | 이화여자대학교 산학협력단 | 유전자의 CpG 메틸화 변화를 이용한 조산 위험성 예측용 조성물 및 이의 이용 |
CN105368931A (zh) * | 2015-10-15 | 2016-03-02 | 天津市泌尿外科研究所 | 尿液中exosome源性miRNAs生物标记物的检测方法 |
US10975436B2 (en) | 2016-01-05 | 2021-04-13 | Diamir, Llc | Methods of using miRNA from bodily fluids for diagnosis and monitoring of neurodevelopmental disorders |
WO2017124000A1 (en) | 2016-01-14 | 2017-07-20 | The Regents Of The University Of California | 3d-exoquant method for the analysis of surface molecules and quantification of tissue-specific exosomes in biological fluids |
US10731166B2 (en) | 2016-03-18 | 2020-08-04 | Caris Science, Inc. | Oligonucleotide probes and uses thereof |
US11149313B2 (en) | 2016-03-21 | 2021-10-19 | Diamir, Llc | Methods of using miRNAs from bodily fluids for detection and differentiation of neurodegenerative diseases |
CA3025486A1 (en) | 2016-05-25 | 2017-11-30 | Caris Science, Inc. | Oligonucleotide probes and uses thereof |
WO2017223116A2 (en) | 2016-06-20 | 2017-12-28 | Healthtell Inc. | Methods for differential diagnosis of autoimmune diseases |
CN109790203A (zh) | 2016-06-20 | 2019-05-21 | 健康之语公司 | 自身免疫疾病的诊断和治疗方法 |
JP6980219B2 (ja) * | 2016-08-22 | 2021-12-15 | いであ株式会社 | がんを検出、又はがんの進行期を判定する方法 |
CN106282360B (zh) * | 2016-08-31 | 2019-11-08 | 武汉博杰生物医学科技有限公司 | 一种用于结肠癌预测转移的血浆miRNA组合、其探针组合物及应用 |
IL259023B (en) | 2016-09-30 | 2022-09-01 | Cellex Life Sciences Incorporated | Preparations containing protein-charged exosomes, methods for their production and uses thereof |
WO2018071806A1 (en) * | 2016-10-13 | 2018-04-19 | University Of Louisville Research Foundation, Inc. | Exosomal biomarkers for diagnosis and prognosis of cancer and related methods |
CN106282387A (zh) * | 2016-10-17 | 2017-01-04 | 上海赛安生物医药科技有限公司 | 胃癌检测引物探针及其试剂盒 |
US20190284629A1 (en) * | 2016-11-11 | 2019-09-19 | University Of Tennessee Research Foundation | Biomarkers for early embryonic viability and methods thereof |
US11371990B2 (en) | 2016-11-11 | 2022-06-28 | Cowper Sciences Inc. | Methods for identifying candidate biomarkers |
WO2018144070A1 (en) * | 2017-02-06 | 2018-08-09 | Goetzl Edward J | Endothelial cell derived exosomes and uses thereof |
WO2018165532A1 (en) | 2017-03-10 | 2018-09-13 | Baylor Research Institute | Methods for diagnosing and treating gastric cancer using mirna expression |
WO2018170624A1 (zh) * | 2017-03-18 | 2018-09-27 | 深圳市博奥康生物科技有限公司 | 降低微小rna-185和微小rna-424表达的方法 |
WO2018199231A1 (ja) * | 2017-04-28 | 2018-11-01 | 一丸ファルコス株式会社 | プラセンタ抽出物 |
WO2018218090A1 (en) * | 2017-05-24 | 2018-11-29 | Nanosomix, Inc. | Detection of biomarkers on vesicles for the diagnosis and prognosis of diseases and disorders |
CN107243012B (zh) * | 2017-05-25 | 2020-01-24 | 江苏大学 | 一种exosomes装载的miR-93-5p在治疗类风湿性关节炎中的应用 |
WO2019008414A1 (en) * | 2017-07-05 | 2019-01-10 | Datar Rajan | GENE EXPRESSION ANALYSIS BASED ON EXOSOMES FOR THE CARE OF CANCER |
EP3652315A4 (en) | 2017-07-12 | 2021-09-01 | Exosome Diagnostics, Inc. | METHOD OF ISOLATION AND ENRICHMENT OF POPULATIONS OF EXTRACELLULAR VESICULES FROM A BIOFLUID AND METHOD OF USING THEREOF |
US10781487B2 (en) | 2017-07-24 | 2020-09-22 | Diamir, Llc | miRNA-based methods for detecting and monitoring aging |
CN107365852B (zh) * | 2017-08-14 | 2021-08-13 | 江苏为真生物医药技术股份有限公司 | 血清外泌体中肺癌相关microRNA分子标记的应用及其检测试剂盒 |
KR102109921B1 (ko) * | 2017-09-27 | 2020-05-12 | ㈜로제타엑소좀 | 크기 배제 크로마토그래피를 이용한 세포밖 소포체의 순도 분석 방법 |
US12000834B2 (en) | 2017-11-10 | 2024-06-04 | Mayo Foundation For Medical Education And Research | Methods and materials for assessing and treating cancer |
CN108753964A (zh) * | 2018-06-04 | 2018-11-06 | 谢丽 | 一种用于非小细胞肺癌诊断及转移预警的试剂盒 |
KR102184911B1 (ko) * | 2019-06-07 | 2020-12-01 | 한림대학교 산학협력단 | miR-548을 함유하는 조산 예방 또는 치료제 조성물 |
US20220275455A1 (en) * | 2019-07-08 | 2022-09-01 | Preferred Networks, Inc. | Data processing and classification for determining a likelihood score for breast disease |
CN110747268B (zh) * | 2019-10-23 | 2023-02-03 | 华南农业大学 | 一种血清外泌体ssc-miR-17-5p作为母猪早期妊娠诊断分子标志物的应用 |
CN110878341A (zh) * | 2019-12-18 | 2020-03-13 | 苏州绘真医学检验有限公司 | 一种检测血液外泌体miRNA的引物组、试剂盒及方法 |
KR102242639B1 (ko) * | 2020-01-28 | 2021-04-21 | 고려대학교 산학협력단 | 간 섬유화 진단용 바이오마커 miRNA4668-5p |
US11211147B2 (en) | 2020-02-18 | 2021-12-28 | Tempus Labs, Inc. | Estimation of circulating tumor fraction using off-target reads of targeted-panel sequencing |
US11475981B2 (en) | 2020-02-18 | 2022-10-18 | Tempus Labs, Inc. | Methods and systems for dynamic variant thresholding in a liquid biopsy assay |
US11211144B2 (en) | 2020-02-18 | 2021-12-28 | Tempus Labs, Inc. | Methods and systems for refining copy number variation in a liquid biopsy assay |
RU2769927C2 (ru) * | 2020-02-28 | 2022-04-08 | Общество с ограниченной ответственностью "МедФлорина" | Способ диагностики меланомы с помощью экзосомальных микроРНК |
WO2021195154A1 (en) * | 2020-03-23 | 2021-09-30 | Avem Holdings, Llc | Isolation and purification of exosomes for regenerative medicine |
US20230332234A1 (en) * | 2020-09-23 | 2023-10-19 | Ewinger, Inc. | Reagents, methods and kits for identifying pregnant human beings at risk for placental bed disorder(s) |
CN112575088B (zh) * | 2020-12-29 | 2022-07-05 | 浙江大学医学院附属妇产科医院 | 一种血浆外泌体miRNA生物标记物及其应用 |
WO2022204378A2 (en) * | 2021-03-24 | 2022-09-29 | City Of Hope | Identification of rna biomarkers in colorectal cancer |
WO2022216765A1 (en) * | 2021-04-07 | 2022-10-13 | Trustees Of Boston University | Exosome-based cancer assays |
CN113736877A (zh) * | 2021-10-15 | 2021-12-03 | 青岛大学附属医院 | 基于微小RNA 27a的子痫前期诊断用途及组合物 |
WO2024050519A2 (en) * | 2022-09-02 | 2024-03-07 | Ohio State Innovation Foundation | Methods and compositions for detecting cancer using exosomal proteins |
CN117802235A (zh) * | 2022-09-30 | 2024-04-02 | 上海思路迪生物医学科技有限公司 | 血液胞外囊泡miRNA在卵巢癌诊断中的应用 |
KR20240058548A (ko) * | 2022-10-26 | 2024-05-07 | 연세대학교 산학협력단 | 유방암 진단 또는 재발 예측을 위한 세포외 소포체 유래 miRNA 유전자 바이오마커 및 이의 용도 |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
US5089181A (en) | 1987-02-24 | 1992-02-18 | Vestar, Inc. | Method of dehydrating vesicle preparations for long term storage |
US5449754A (en) | 1991-08-07 | 1995-09-12 | H & N Instruments, Inc. | Generation of combinatorial libraries |
US6015880A (en) | 1994-03-16 | 2000-01-18 | California Institute Of Technology | Method and substrate for performing multiple sequential reactions on a matrix |
US5807522A (en) | 1994-06-17 | 1998-09-15 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for fabricating microarrays of biological samples |
IL131978A0 (en) | 1997-03-20 | 2001-03-19 | Univ Washington | Solvent for biopolymer synthesis solvent microdots and methods of use |
US6242266B1 (en) | 1999-04-30 | 2001-06-05 | Agilent Technologies Inc. | Preparation of biopolymer arrays |
US6180351B1 (en) | 1999-07-22 | 2001-01-30 | Agilent Technologies Inc. | Chemical array fabrication with identifier |
US6232072B1 (en) | 1999-10-15 | 2001-05-15 | Agilent Technologies, Inc. | Biopolymer array inspection |
US6171797B1 (en) | 1999-10-20 | 2001-01-09 | Agilent Technologies Inc. | Methods of making polymeric arrays |
US6812023B1 (en) | 2000-04-27 | 2004-11-02 | Anosys, Inc. | Methods of producing membrane vesicles |
JP2002330055A (ja) * | 2001-04-27 | 2002-11-15 | Tdk Corp | 表面弾性波フィルタ、表面弾性波フィルタ用パッケージ及び表面弾性波フィルタモジュール |
US20030036077A1 (en) | 2001-05-31 | 2003-02-20 | Chronix Biomedical | Methods for generating an mRNA expression profile from an ecellular mRNA containing blood sample and using the same to identify functional state markers |
US20050158708A1 (en) | 2001-06-06 | 2005-07-21 | Iris Alroy | Methods and compositions related to tagging of membrane surface proteins |
CN1753993A (zh) * | 2002-12-18 | 2006-03-29 | 第三次浪潮技术公司 | 小核酸的检测 |
WO2005114192A1 (en) | 2004-05-13 | 2005-12-01 | Centre National De La Recherche Scientifique | A device for binding a target entity to a bait entity and detection methods using the same |
US8021847B2 (en) | 2004-06-02 | 2011-09-20 | Proxy Life Science Holdings, Inc. | Microvesicle-based compositions and methods |
EP1766053A4 (en) * | 2004-06-02 | 2007-12-12 | Sourcepharm Inc | MICROVESICLES CONTAINING RNA AND METHODS |
CA2573164A1 (en) * | 2004-07-09 | 2006-01-26 | Chronix Biomedical | Detection of nucleic acids to assess risk for bovine spongiform encephalopathy |
WO2006102687A1 (en) | 2005-03-22 | 2006-09-28 | The Trustees Of Columbia University In The City Of New York | A liposome-based microarray and methods of use thereof |
AU2006242154B2 (en) * | 2005-05-02 | 2011-11-03 | Cold Spring Harbor Laboratory | Composition and methods for cancer diagnosis utilizing the mir 17-92 cluster |
WO2007084962A2 (en) | 2006-01-18 | 2007-07-26 | The Regents Of The University Of California | A fluid membrane-based ligand display system for live cell assays and disease diagnosis applications |
EP2117305A4 (en) | 2007-01-26 | 2011-03-30 | Univ Louisville Res Found | MODIFICATION OF EXOXIC COMPONENTS USED AS VACCINE |
ATE535805T1 (de) | 2007-01-26 | 2011-12-15 | Univ Louisville Res Found | Verfahren zur erkennung von autoantikörpern zur diagnostizierung und charakterisierung von erkrankungen |
EP2613149B1 (en) * | 2007-07-25 | 2014-09-17 | University Of Louisville Research Foundation, Inc. | Exosome-associated microRNA as a diagnostic marker |
CA2699646A1 (en) | 2007-09-14 | 2009-03-19 | The Ohio State University Research Foundation | Mirna expression in human peripheral blood microvesicles and uses thereof |
CN102301002A (zh) | 2008-11-12 | 2011-12-28 | 卡里斯生命科学卢森堡控股有限责任公司 | 使用外来体来确定表现型的方法和系统 |
US20130288258A1 (en) * | 2012-04-27 | 2013-10-31 | University Of Louisville Research Foundation, Inc. | METHODS AND COMPOSITIONS FOR DETECTING COLORECTAL CANCER USING MICRO RNAs |
-
2008
- 2008-07-25 EP EP13162506.3A patent/EP2613149B1/en active Active
- 2008-07-25 EP EP14180889.9A patent/EP2806273B1/en active Active
- 2008-07-25 EP EP08796656.0A patent/EP2181332B1/en active Active
- 2008-07-25 US US12/524,462 patent/US8216784B2/en active Active
- 2008-07-25 JP JP2010518421A patent/JP5156829B2/ja active Active
- 2008-07-25 CN CN2013101656263A patent/CN103276062A/zh active Pending
- 2008-07-25 GB GB0914442.9A patent/GB2459228B/en active Active
- 2008-07-25 CA CA2676113A patent/CA2676113C/en active Active
- 2008-07-25 AU AU2008279016A patent/AU2008279016B2/en active Active
- 2008-07-25 BR BRPI0807318A patent/BRPI0807318B8/pt active IP Right Grant
- 2008-07-25 ES ES08796656T patent/ES2420973T3/es active Active
- 2008-07-25 WO PCT/US2008/071235 patent/WO2009015357A1/en active Application Filing
- 2008-07-25 CN CN200880025224.0A patent/CN101755208B/zh active Active
-
2009
- 2009-07-23 IL IL200028A patent/IL200028A/en active IP Right Grant
-
2010
- 2010-02-24 US US12/711,499 patent/US8637254B2/en active Active
-
2012
- 2012-06-06 US US13/489,686 patent/US20120238467A1/en not_active Abandoned
- 2012-12-10 JP JP2012269463A patent/JP5291241B2/ja active Active
-
2013
- 2013-04-05 JP JP2013079686A patent/JP5383940B2/ja active Active
-
2015
- 2015-10-29 IL IL242337A patent/IL242337A/en active IP Right Grant
-
2016
- 2016-12-16 US US15/381,668 patent/US20170137892A1/en not_active Abandoned
-
2017
- 2017-04-30 IL IL252040A patent/IL252040B/en active IP Right Grant
-
2018
- 2018-11-19 US US16/195,274 patent/US20190085410A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0807318B8 (pt) | "microrna associado a exossomos como marcador diagnóstico" | |
ES2527592T3 (es) | Métodos basados en microARN para el diagnóstico del cáncer de colon | |
BR112014015152A2 (pt) | métodos e materiais para a avaliação da perda de heterozigosidade | |
BRPI0518302A2 (pt) | mÉtodo de formaÇço de imagens por rm | |
BR112015011118A2 (pt) | conjugado; composição farmacêutica; e uso de um ou mais dos conjugados | |
BR112013024190A2 (pt) | microdispositivo para detectar ou tratar doença e métodos para fabricar microdispositivo e para detectar doença em indivíduo em necessidade do mesmo | |
PE20120015A1 (es) | Metodos y sistemas para predecir la respuesta de las celulas tumorales a un agente terapeutico | |
BR112015001898A2 (pt) | sistema para identificar artefatos de movimentação; e método para identificar artefatos de movimentação | |
AR084723A1 (es) | microARN (miARN) COMO BIOMARCADOR PARA LA IDENTIFICACION DEL CANCER COLORRECTAL FAMILIAR Y NO FAMILIAR | |
BRPI0821003B8 (pt) | método para aumentar a imunorreatividade | |
BRPI0923871B8 (pt) | compostos dipirrometenos substituídos por boro fluorescentes e uso dos mesmos para diagnósticos | |
UY32009A (es) | 5-alquinil-pirimidinas | |
AR088244A1 (es) | oxMIF COMO MARCADOR DE DIAGNOSTICO | |
ECSP11010816A (es) | Nuevos Compuestos | |
CO6450654A2 (es) | Identificación de moléculas pequeñas reconocidas por anticuerpos en sujetos con enfermedades neurodegenerativas | |
BR112014009223A8 (pt) | método para o diagnóstico da doença de niemann-pick | |
BR112014031957A2 (pt) | bag3 como soro bioquímico e marcador de tecido | |
BRPI1014222A2 (pt) | composto, composição farmacêutica,e, métodos para tratar distúrbio(s) cognitivo(s) ou indicações com déficit(s) na cognição, mal de alzheimer, e distúrbio bipolar | |
BR112013031431A2 (pt) | método para o diagnóstico da doença de gaucher | |
BR112015027249A2 (pt) | método de diagnóstico de câncer | |
CO6460762A2 (es) | 5-alquinil-piridinas | |
BR112014032555A2 (pt) | nalmefeno para a redução do consumo de álcool em populações alvo específicas | |
BR112015028997A2 (pt) | biomarcadores de expressão gênica e seu uso para a aplicação diagnóstica e prognóstica em pacientes potencialmente com necessidade de tratamento de inibidor de hdac | |
BR112013003793A2 (pt) | método de diagnóstico das doenças neurodegenerativas | |
ES2570609T3 (es) | Método para someter a ensayo la aminoacilasa 1 para el diagnóstico in vitro del cáncer colorrectal |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B08E | Application fees: payment of additional fee required [chapter 8.5 patent gazette] |
Free format text: COMPLEMENTAR A RETRIBUICAO DA(S) 4A. E 5A. ANUIDADE(S), DE ACORDO COM TABELA VIGENTE, REFERENTE A(S) GUIA(S) DE RECOLHIMENTO 22110877908-0 E 22120443528-0, RESPECTIVAMENTE. |
|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 4A E 5A ANUIDADES (COMPLEMENTACAO). |
|
B08H | Application fees: decision cancelled [chapter 8.8 patent gazette] | ||
B08G | Application fees: restoration [chapter 8.7 patent gazette] | ||
B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 13/11/2018, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 25/07/2008, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO |